Qube Research & Technologies (QRT)
FBRX

Qube Research & Technologies (QRT)’s Forte Biosciences FBRX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-85,969
Closed -$2.23M – 3661
2026
Q1 		$2.23M Buy
85,969
+53,782
+167% +$1.55M ﹤0.01% 2103
2025
Q4 		$878K Buy
+32,187
New +$564K ﹤0.01% 2606
2024
Q3 		– Hold
0
– -$2 – 3542
2024
Q2 		– Hold
0
– – – 3686
2024
Q1 		– Hold
0
– – – 4365
2023
Q4 		– Hold
0
– – – 4241
2023
Q3 		– Hold
0
– – – 4008
2021
Q2 		– Sell
-245
Closed -$210K – 2422
2021
Q1 		$210K Sell
245
-1,077
-81% -$882K ﹤0.01% 1633
2020
Q4 		$1.2M Sell
1,322
-424
-24% -$399K 0.02% 810
2020
Q3 		$2.12M Buy
+1,746
New +$1.16M 0.03% 616

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Qube Research & Technologies (QRT)'s FBRX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Forte Biosciences (FBRX) in Q2 2026, closing a stake of 85,969 shares — an estimated $2.23M sold.

Qube Research & Technologies (QRT) first reported a position in FBRX in Q3 2020 and held it in 5 quarters. The position peaked at $2.23M in Q1 2026. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Forte Biosciences position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 85,969 Forte Biosciences shares in Q2 2026, an estimated $2.23M.
  • Qube Research & Technologies (QRT) first reported a position in Forte Biosciences in Q3 2020 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Forte Biosciences position peaked at $2.23M in Q1 2026.
  • 86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.